Phil Lynch
Follow
Get notifications in MyBN when activity occurs.
Phil Lynch
Chief Executive, Managing Director / Race Oncology
Phillip Lynch has over 15 years of experience in commercial leadership with Johnson & Johnson, bringing M&A experience and strong relationships in the Asia Pacific region.
He is also an experienced company director with a diverse background across corporate development, strategy, financial performance, marketing and governance.
Mr Lynch is a Business graduate from Monash University, completed postgraduate studies at the University of Virginia Darden Business School, and is a graduate of the Australian Institute of Company Directors.
He is also an experienced company director with a diverse background across corporate development, strategy, financial performance, marketing and governance.
Mr Lynch is a Business graduate from Monash University, completed postgraduate studies at the University of Virginia Darden Business School, and is a graduate of the Australian Institute of Company Directors.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1228th | Aeeris | -34% | 9% |
| 1596th | Magnetite Mines | -59% | 3% |
| 1622nd | Race Oncology | -60% | 60% |
| 1671st | Westar Resources | -65% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 905th |  | Race Oncology | $3.1m |
| 912th | | Aeeris | $3.0m |
| 1086th | | Magnetite Mines | $213k |
| 1090th | | Westar Resources | $196k |
| 1091st | | Tamboran Resources | $194k |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Chief Executive, Managing Director, Race Oncology | 03 Nov 2020 |
